세계의 디프테리아 시장 보고서(2025년)

Diphtheria is a bacterial disease caused by strains of bacteria known as Corynebacterium diphtheriae. These bacteria produce a toxin that primarily affects the mucous membranes of the throat and nose and can also impact other parts of the body, particularly in severe cases. Diphtheria is characterized by symptoms such as throat discomfort, weakness, fever, swollen neck glands, breathing difficulties due to the blockage of tissues in the nose and throat, and swallowing difficulties.

The main types of infections related to diphtheria encompass diphtheria, skin diphtheria, and others. Diphtheria is a dangerous bacterial infection that can affect the tonsils, nose, throat, and/or skin and is caused by toxin-producing Corynebacterium diphtheriae bacteria. Diagnosis typically involves a physical examination and throat culture and can be confirmed with the use of antibiotics, antitoxins, and other treatment approaches. Diphtheria-related products and treatments are distributed through various channels, including hospital pharmacies, online pharmacies, and retail pharmacies. These products and therapies are employed in a range of healthcare settings, including hospitals, homecare, specialty clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The diphtheria market research report is one of a series of new reports from The Business Research Company that provides diphtheria market statistics, including diphtheria industry global market size, regional shares, competitors with a diphtheria market share, detailed diphtheria market segments, market trends and opportunities and any further data you may need to thrive in the diphtheria industry. This diphtheria market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diphtheria market size has grown strongly in recent years. It will grow from $8.91 billion in 2024 to $9.39 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to vaccine development, immunization campaigns, increased awareness, healthcare infrastructure.

The diphtheria market size is expected to see strong growth in the next few years. It will grow to $12.1 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to emerging outbreaks, booster vaccination programs, global travel and migration, public health preparedness. Major trends in the forecast period include combination vaccines, telemedicine for vaccination, vaccine equity initiatives, public-private partnerships.

The forecast of 6.5% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. public health by increasing the cost of diphtheria antitoxin and DTaP vaccine components sourced from Canada and Germany, thereby risking immunization gaps and elevating emergency preparedness costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of bacterial infections is expected to drive the growth of the diphtheria market in the coming years. Bacterial infections occur when bacteria invade the body, causing illness either through direct infection or by producing toxins. Diphtheria, a serious bacterial infection, is caused by strains of Corynebacterium diphtheriae, which weaken the immune system and promote bacterial growth. For example, in September 2024, according to GOV.UK, a UK government website, NHS acute trusts in England reported 38,757 cases of E. coli bacteremia during the fiscal year 2022-2023, with 7,881 (20.3%) of these cases being hospital-onset infections. As bacterial infections continue to rise, the diphtheria market is expected to grow accordingly.

The diphtheria market is experiencing growth, largely underpinned by the upward trajectory of immunization programs. Immunization programs encompass a suite of services aimed at safeguarding individuals against vaccine-preventable illnesses by delivering vaccinations. These programs are designed to curtail sickness, disability, and mortality stemming from vaccine-preventable maladies. Diphtheria and other vaccines are routinely administered to individuals through immunization initiatives spanning different countries and regions. For instance, in July 2023, the United Nations International Children's Emergency Fund (UNICEF) reported an uptick in global coverage for the third dose of the Diphtheria, Tetanus, Pertussis (DTP3) vaccination. This coverage increased from 81% in 2021 to 84% in 2022 through immunization efforts. Consequently, the escalating prominence of immunization programs is a propellant behind the growth of the diphtheria market.

Companies engaged in the diphtheria market are actively innovating and securing FDA approvals to maintain their market positions. A prime example of such innovation occurred in October 2022 when GlaxoSmithKline PLC, a U.K.-based pharmaceutical and biotechnology firm, announced that the U.S. Food and Drug Administration (FDA) granted approval for BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, adsorbed; Tdap). This approval permits immunization during the third trimester of pregnancy to prevent pertussis (whooping cough) in infants under two months old. Administering the Tdap vaccine to pregnant women confers optimal protection against whooping cough for newborns during their initial months of life through the transference of protective antibodies from mother to child.

In December 2022, Pharmaniaga LifeScience Sdn Bhd (PLS), a pharmaceutical company headquartered in Malaysia, initiated a collaborative research agreement with BioNet-Asia Co. Ltd. (BioNet) for an undisclosed sum. This partnership focuses on the research and development of a 6-in-1 Hexavalent Vaccine targeting diseases like diphtheria (DT), tetanus (TT), pertussis (aP), poliomyelitis (IPV), Haemophilus influenzae type b (Hib), and hepatitis B (Hep-B). The collaboration is in line with Pharmaniaga's objective to establish the world's first Halal vaccine and insulin manufacturing facilities. This initiative aims to reduce Malaysia's reliance on imported life-saving vaccines and insulin, fostering the nation's goal of vaccine self-sufficiency. BioNet-Asia Co. Ltd. is a Thailand-based company specializing in the development and manufacturing of life-saving vaccines against bacterial infections, including diphtheria and tetanus.

Major companies operating in the diphtheria market are Pfizer Inc., Johnson & Johnson Co, Roche Holding AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Serum Institute of India, Novavax Inc., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Bharat Biotech International Limited, CureVac AG, Inovio Pharmaceuticals Inc., The Native Antigen Company.

Asia-Pacific was the largest region in the diphtheria market in 2024. The regions covered in diphtheria report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the diphtheria market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diphtheria market consists of revenues earned by entities by providing services such as consultation, diagnosis and treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. The diphtheria market also includes the sales of medications such as vaccines, antibiotics and antitoxins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diphtheria Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diphtheria market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diphtheria ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diphtheria market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Diphtheria; Skin Diphtheria; Other Types
• 2) By Diagnosis: Physical Examination; Throat Culture; Other Diagnosis
• 3) By Treatment: Antibiotics; Antitoxin; Other Treatments
• 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• 5) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Diphtheria: Respiratory Diphtheria; Non-respiratory Diphtheria
• 2) By Skin Diphtheria: Cutaneous Diphtheria
• 3) By Other Types: Diphtheritic Myocarditis; Diphtheritic Neuritis
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Co; Roche Holding AG; Merck & Co Inc.; AbbVie Inc.; Novartis AG; Sanofi SA; Bristol-Myers Squibb Co.; AstraZeneca plc; GlaxoSmithKline plc; Eli Lilly and Company; Gilead Sciences Inc.; Amgen Inc.; Moderna Inc.; BioNTech SE; Regeneron Pharmaceuticals Inc.; Biogen Inc.; Vertex Pharmaceuticals Inc.; Serum Institute of India; Novavax Inc.; Sinovac Biotech Ltd.; Emergent BioSolutions Inc.; Dynavax Technologies Corporation; Bharat Biotech International Limited; CureVac AG; Inovio Pharmaceuticals Inc.; The Native Antigen Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Diphtheria Market Characteristics

3. Diphtheria Market Trends And Strategies

4. Diphtheria Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Diphtheria Growth Analysis And Strategic Analysis Framework

• 5.1. Global Diphtheria PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Diphtheria Market Growth Rate Analysis
• 5.4. Global Diphtheria Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Diphtheria Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Diphtheria Total Addressable Market (TAM)

6. Diphtheria Market Segmentation

• 6.1. Global Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diphtheria
• Skin Diphtheria
• Other Types
• 6.2. Global Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Examination
• Throat Culture
• Other Diagnosis
• 6.3. Global Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Antitoxin
• Other Treatments
• 6.4. Global Diphtheria Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.5. Global Diphtheria Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End-Users
• 6.6. Global Diphtheria Market, Sub-Segmentation Of Diphtheria, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Respiratory Diphtheria
• Non-respiratory Diphtheria
• 6.7. Global Diphtheria Market, Sub-Segmentation Of Skin Diphtheria, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cutaneous Diphtheria
• 6.8. Global Diphtheria Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Myocarditis
• Diphtheritic Neuritis

7. Diphtheria Market Regional And Country Analysis

• 7.1. Global Diphtheria Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Diphtheria Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diphtheria Market

• 8.1. Asia-Pacific Diphtheria Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diphtheria Market

• 9.1. China Diphtheria Market Overview
• 9.2. China Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diphtheria Market

• 10.1. India Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diphtheria Market

• 11.1. Japan Diphtheria Market Overview
• 11.2. Japan Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diphtheria Market

• 12.1. Australia Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diphtheria Market

• 13.1. Indonesia Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diphtheria Market

• 14.1. South Korea Diphtheria Market Overview
• 14.2. South Korea Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diphtheria Market

• 15.1. Western Europe Diphtheria Market Overview
• 15.2. Western Europe Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diphtheria Market

• 16.1. UK Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diphtheria Market

• 17.1. Germany Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diphtheria Market

• 18.1. France Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diphtheria Market

• 19.1. Italy Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diphtheria Market

• 20.1. Spain Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diphtheria Market

• 21.1. Eastern Europe Diphtheria Market Overview
• 21.2. Eastern Europe Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diphtheria Market

• 22.1. Russia Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diphtheria Market

• 23.1. North America Diphtheria Market Overview
• 23.2. North America Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diphtheria Market

• 24.1. USA Diphtheria Market Overview
• 24.2. USA Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diphtheria Market

• 25.1. Canada Diphtheria Market Overview
• 25.2. Canada Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diphtheria Market

• 26.1. South America Diphtheria Market Overview
• 26.2. South America Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diphtheria Market

• 27.1. Brazil Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diphtheria Market

• 28.1. Middle East Diphtheria Market Overview
• 28.2. Middle East Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diphtheria Market

• 29.1. Africa Diphtheria Market Overview
• 29.2. Africa Diphtheria Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Diphtheria Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Diphtheria Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diphtheria Market Competitive Landscape And Company Profiles

• 30.1. Diphtheria Market Competitive Landscape
• 30.2. Diphtheria Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Co Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Diphtheria Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Sanofi SA
• 31.3. Bristol-Myers Squibb Co.
• 31.4. AstraZeneca plc
• 31.5. GlaxoSmithKline plc
• 31.6. Eli Lilly and Company
• 31.7. Gilead Sciences Inc.
• 31.8. Amgen Inc.
• 31.9. Moderna Inc.
• 31.10. BioNTech SE
• 31.11. Regeneron Pharmaceuticals Inc.
• 31.12. Biogen Inc.
• 31.13. Vertex Pharmaceuticals Inc.
• 31.14. Serum Institute of India
• 31.15. Novavax Inc.

32. Global Diphtheria Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diphtheria Market

34. Recent Developments In The Diphtheria Market

35. Diphtheria Market High Potential Countries, Segments and Strategies

• 35.1 Diphtheria Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Diphtheria Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Diphtheria Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer